viernes, 18 de octubre de 2019

These four companies are betting big on CBD-based prescription drugs

These four companies are betting big on CBD-based prescription drugs

Daily Recap

STAT Plus: These four companies are betting big on CBD-based prescription drugs

By NICHOLAS FLORKO


HANS PENNINK/AP
A number of pharmaceutical companies are shepherding their CBD-based products through the lengthy and expensive FDA approval process for medicine.

No hay comentarios: